Announcing GTC's Biotechnology Transfer & Commercialization Conference
October 24-26, 2012 in Philadelphia, PA
Register today to get a 20% off early registration discount!

Dear Colleague,

A gulf exists between early research and commercial drug development. What is considered adequately researched at an academic level is vastly different than what is required on a commercial level. Taking the research of successful therapies into the mainstream market is challenging and requires significant investments. An era of biotech business paradigm shifts requires a new understanding among the various market segments.

We invite you to attend the Biotechnology Transfer & Commercialization Conference taking place on October 24-26, 2012 in Philadelphia, PA. This exciting event will provide networking opportunities for dialogue with every level engaged in drug development. Leading universities, pharmaceutical companies, venture capital, foundations and biotech companies will come together to share their perspectives, discuss new models of cooperation and develop the business relationships that get deals done.

Topics to be discussed:

  • Market Overview for Emerging Life Science Companies
  • IP Update Presentation
  • Life Science M&A Outlook
  • Panel Discussions with Pharma and VCs
  • University Presentations & Panel
  • A Perspective from Foundations
  • Case Study - Bridging the Valley of Death

    At GTC’s Biotechnology Transfer & Commercialization Conference, network with the players who move the industry forward and discuss potential partnerships and strategies to develop new drug therapies for the treatment of diseases ranging from Alzheimer’s to cancer to cystic fibrosis to HIV/AIDS and many others.

    Sign up for the Conference and receive a 20% discount!
    Or bring your team!
    Register 2 people at the regular price, bring a 3rd person for free! Use discount code rcdvb.


  • DISTINGUISHED SPEAKERS AND PANELISTS

    Vivian Berlin, Ph.D., Director of Business Development, Harvard University Office of Technology Development

    David Berry, MD, Ph.D., Partner, Flagship Ventures

    Wesley D. Blakeslee, Executive Director, Technology Transfer, Johns Hopkins University

    Kristina Burow, Managing Director, ARCH Venture Partners

    Margarita Chavez, Director, Venture Investments, Abbott Biotech Ventures

    Brenda Gavin, Founding Partner, Quaker Partners Management

    Elizabeth Hart-Wells, Assistant Vice-President and Director, Purdue Research Foundation

    Yuji Iizawa, Ph.D., Vice President, Takeda Ventures

    Raymond Jordt, Director, Corporate Business Development, Eli Lilly

    Nina Kjellson, General Partner, InterWest

    David Lewin, Senior Associate Director of Licensing, Yale University

    Keith S. Marmer, DPT, MBA, Associate Dean for Research Innovation; Director, Office of Technology Development, Penn State College of Medicine

    Dushyant Pathak, Associate Vice Chancellor, Technology Management & Corporate Relations, UC Davis

    Brendan Rauw, Associate Vice Chancellor and Executive Director of Entrepreneurship, UCLA Office of Intellectual Property & Industry Sponsored Research

    Scott A. Siegel, Ph.D., Vice President, Business Development, Ezose Sciences

    Bill Thies, Ph.D., Chief Medical and Scientific Officer, Alzheimer’s Association

    ...and many more!!!

    For an updated speaker list, click here.
    Register today and save up to $350!
    Sign up 3 people for the price of 2! Use discount code rcdvb.
     

    For Business Development & Exhibiting Opportunities contact Maribel Cortes at spex@gtcbio.com


    Upcoming Conferences
     

    2nd Infectious Diseases World Summit
    July 9-10, 2012, San Francisco, CA

    9th Anti-Infectives Partnering & Deal-making
    July 9-10, 2012, San Francisco, CA

    10th Vaccines Research & Development:
    All Things Considered

    July 9-10, 2012, San Francisco, CA

    Influenza Research and Development
    July 9-10, 2012, San Francisco, CA


    2nd CNS Diseases World Summit
    September 13-14, 2012, San Francisco, CA
    20% discount by July 13th

    6th Neurdegenerative Conditions Research and Development
    September 13-14, 2012, San Francisco, CA
    20% discount by July 13th

    2nd Neuropsychiatric Research and Development
    September 13-14, 2012, San Francisco, CA
    20% discount by July 13th

    5th CNS Partnering and Deal-making
    September 13-14, 2012, San Francisco, CA
    20% discount by July 13th

    Pain Research and Therapeutics
    September 13-14, 2012, San Francisco, CA
    20% discount by July 13th


    3rd Biobased Chemicals: Commercialization & Partnering
    September 13-14, 2012, San Francisco, CA
    20% discount by July 13th

    2nd Biomarker Europe Summit
    September 5-7, 2012, Zurich, Switzerland
    20% discount by July 5th

    5th Oncology Biomarkers
    September 5-6, 2012, Zurich, Switzerland
    20% discount by July 5th

    Neurological Biomarkers
    September 6-7, 2012, Zurich, Switzerland
    20% discount by July 5th

    Inflammatory Biomarkers
    September 6-7, 2012, Zurich, Switzerland
    20% discount by July 5th
     

    Drug Delivery Technologies & Formulation
    September 5-6, 2012, Zurich, Switzerland
    20% discount by July 5th
     

    Modern Drug Discovery and Development (M3D) Summit
    October 24-26, 2012, Philadelphia, PA

    9th Stem Cell Research and Therapeutics
    October 24-26, 2012, Philadelphia, PA

    7th Assay and Drug Discovery Technologies
    October 24-26, 2012, Philadelphia, PA

    4th Translation Medicine
    October 24-26, 2012, Philadelphia, PA

    3rd Pharmacokinetics and Pharmacodynamics
    October 24-26, 2012, Philadelphia, PA

     

    3rd Cancer Immunotherapy and Immunomonitoring
    (CITIM 2013)

    April 22 - 25, 2013
    Krakow, Poland, POL

    This advertisement is sent to !*EMAIL*! from GTC, 635 W. Foothill Blvd, Monrovia, CA 91016. If you prefer not to receive further messages from this sender, please forward this email to remove@gtcinsight.com or use the following link to unsubscribe http://gtcbio.com/unsubscribe.php?emailid=!*EMAIL*!